News and Trends 10 Dec 2021
European Biotech Investors Cap Off Record Year in Fundraising
The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health Ventures, and Merck’s venture capital…
Medicxi Ventures
- Latest Posts
News and Trends 1 Oct 2020
Medicxi to Shake up the Biotech VC Investment Model with €200M Fund
UK-based investment firm Medicxi aims to attract more investors to the life sciences with a new fund that lets them…
More News! 19 Jul 2019
UK VC Medicxi Closes Third Fund with €400M to Boost European Biotech
The UK-based venture capital investment firm Medicxi has closed its third fund, totaling €400M, to nurture early- and late-stage healthcare…
News and Trends 8 Jul 2019
Evotec Spinoff to Develop Cancer Drugs that Block DNA Repair
Breakpoint Therapeutics, a spinoff from the German biotech Evotec, has raised €30M to develop drugs that block DNA repair mechanisms…
ADVERTISEMENT
Best in Biotech 28 Dec 2017
Bored Between the Holidays? Watch these Biotech Videos!
Christmas might have passed, but we have more videos for you to watch on a dreary winter day! Here are…
Interview 2 Nov 2017
Meet the Top Biotech Investor Who Picked His Career By Accident
Kevin Johnson, Partner at Medicxi, joined us last week for our Meetup in London. He told us how he ended…
Interview 4 Sep 2017
Meet this Blockbuster Developer turned Partner at a Headlining VC
Kevin Johnson told me the story and lessons of his career, from CTO of Cambridge Antibody Technology to General Partner…
News and Trends 13 Jul 2017
Why European Biotech Startups Should Attend American Conferences!
We all know conferences are important. To be on the same page, let’s brainstorm the word. What comes to mind?…
News and Trends 15 Jun 2017
UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech
The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and Google's Verily to invest in…
More News! 7 Mar 2017
UPDATE: Reproductive Health Biotech starts Phase III after €90M IPO
UPDATE (07/03/2017): ObsEva has announced the start of its Phase III trials for nolasiban, an oral oxytocin receptor antagonist. It is…
More News! 9 Feb 2017
After its First Success, the Virtual Biotech Team is Back at it Again
SuperX has raised €10.3M ($11M) in Series A from Medicxi and J&J Innovation to develop anticoagulant antibodies for stroke and…
News and Trends 28 Dec 2016
Discussing the Future of Personalized Medicine with Biotech Experts
Personalized medicine has been a popular topic in the last few years, but when will it materialize? Experts discussed the…
News and Trends 26 Dec 2016
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash…
News and Trends 18 Oct 2016
This New Biotech wants to Regrow Neurons to cure Parkinson’s
Mavalon Therapeutics will develop a drug candidate for Parkinson's that can stop the disease progression by activating the growth of…
Best in Biotech 12 Apr 2016
18 of the Best European VCs for Biotech in 2016
As Genentech is celebrating its 40th Birthday, it is also the 40th birthday of Biotechnology and the 40th birthday of…
News and Trends 30 Mar 2016
Dutch Startup gets €7M for New Cancer Immunotherapy Platform
Gadeta has raised €7M in a series A round, which will fuel the clinical development of its novel TCR platform,…
ADVERTISEMENT
News and Trends 10 Mar 2016
Antibody Start-up Gets a Slice of a Rebranded €210M Life Sciences Fund
Capella Biosciences (UK) is a life sciences start-up specializing in antibodies. It has just raised an additional €14.3M in a Series…
News and Trends 2 Feb 2016
New €210M Life Sciences Fund is Launched in UK
Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210M Fund including…
